stage iv prostate cancer
Showing 26 - 50 of 94
Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City
Completed
- Adenocarcinoma of the Prostate
- +5 more
- sipuleucel-T
- +2 more
-
Duarte, California
- +2 more
Aug 21, 2020
Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer Trial (Image Guided Biopsy)
Withdrawn
- Castration-Resistant Prostate Carcinoma
- +2 more
- Image Guided Biopsy
- (no location specified)
Jul 22, 2020
Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma, Stage IV Prostate Cancer Trial in Salt Lake City
Terminated
- Castration-Sensitive Prostate Carcinoma
- +4 more
- Abiraterone Acetate
- +5 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Jun 5, 2020
Bone Metastases, Castrate-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Chicago (drug, other, procedure)
Completed
- Bone Metastases
- +3 more
- cabozantinib
- +2 more
-
Chicago, IllinoisUniversity of Chicago
Mar 25, 2020
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,
Completed
- Adenocarcinoma of the Prostate
- +5 more
- sodium selenite
- +4 more
-
Stanford, CaliforniaStanford University, School of Medicine
Feb 14, 2020
Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Rochester (Goserelin Acetate, Laboratory
Terminated
- Prostate Adenocarcinoma
- +4 more
- Goserelin Acetate
- +3 more
-
Rochester, MinnesotaMayo Clinic
Dec 9, 2019
Stage III Prostate Cancer, Stage IIIA Prostate Cancer, Stage IIIB Prostate Cancer Trial (biological, radiation, procedure)
Withdrawn
- Stage III Prostate Cancer
- +6 more
- Ipilimumab
- +3 more
- (no location specified)
Nov 7, 2019
Stage IV Prostate Cancer, Stage IV Colon Cancer, Stage IV Breast Cancer Trial in Kingston (Dibenzyl trisulphide capsules, Stage
Unknown status
- Stage IV Prostate Cancer
- +3 more
- Dibenzyl trisulphide capsules
- +4 more
-
Kingston, JamaicaFaculty of Medial Sciences
Oct 3, 2019
Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Columbus, Dublin (dietary intervention
Completed
- Stage I Prostate Cancer
- +4 more
- dietary intervention (tangerine tomato juice)
- +3 more
-
Columbus, Ohio
- +1 more
Aug 29, 2019
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in United States
Completed
- Castration Levels of Testosterone
- +3 more
- Glycosylated Recombinant Human Interleukin-7
- Laboratory Biomarker Analysis
-
La Jolla, California
- +15 more
Jun 25, 2019
Castration-resistant Prostate Cancer, Stage IV Prostate Cancer Trial in Singapore, United States (abiraterone acetate)
Completed
- Castration-resistant Prostate Cancer
- Stage IV Prostate Cancer
- abiraterone acetate
-
Atlanta, Georgia
- +5 more
Jul 2, 2019
Adenocarcinoma of the Prostate, Stage I Prostate Cancer, Stage II Prostate Cancer Trial in Richmond (intensity modulated
Completed
- Adenocarcinoma of the Prostate
- +4 more
- intensity modulated external beam radiation therapy
-
Richmond, Virginia
- +1 more
Jun 27, 2019
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (biological,
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Cixutumumab
- +2 more
-
Chicago, Illinois
- +3 more
May 21, 2019
Advanced Malignant Tumor, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma Trial in Scottsdale, Rochester (Laboratory
Completed
- Advanced Malignant Neoplasm
- +31 more
- Laboratory Biomarker Analysis
- +2 more
-
Scottsdale, Arizona
- +1 more
Jun 5, 2019
Prostate Adenocarcinoma, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer Trial in Seattle (drug, radiation, other)
Completed
- Prostate Adenocarcinoma
- +4 more
- Degarelix
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2018
Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)
Terminated
- Adenocarcinoma of the Prostate
- +4 more
-
Seattle, WashingtonSeattle Cancer Care Alliance/University of Washington
Nov 6, 2018
Adenocarcinoma of the Prostate, Bone Metastases, Soft Tissue Metastases Trial in Aurora (Ranolazine)
Completed
- Adenocarcinoma of the Prostate
- +6 more
-
Aurora, ColoradoUniversity of Colorado Cancer Center
Nov 29, 2018
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- Hsp90 inhibitor STA-9090
- +7 more
-
Baltimore, Maryland
- +3 more
Aug 19, 2018
Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in United States (Laboratory
Completed
- Hormone-Resistant Prostate Cancer
- +3 more
- Laboratory Biomarker Analysis
- +2 more
-
Washington, District of Columbia
- +19 more
Aug 13, 2018
Adenocarcinoma of the Prostate, Stage IV Prostate Cancer Trial in Detroit, Houston, Madison (cediranib maleate, docetaxel,
Terminated
- Adenocarcinoma of the Prostate
- Stage IV Prostate Cancer
- cediranib maleate
- +3 more
-
Detroit, Michigan
- +3 more
Jul 13, 2018
Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Baltimore (Dexamethasone,
Terminated
- Hormone-Resistant Prostate Cancer
- +3 more
- Dexamethasone
- +3 more
-
Baltimore, MarylandJohns Hopkins University/Sidney Kimmel Cancer Center
Jul 11, 2018
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer Trial in Canada, United States (drug,
Completed
- Prostate Adenocarcinoma
- +2 more
- Bicalutamide
- +5 more
-
Fairbanks, Alaska
- +169 more
Feb 23, 2018
Stage IV Prostate Cancer Trial in Houston (Antineoplaston therapy (Atengenal + Astugenal))
Withdrawn
- Stage IV Prostate Cancer
- Antineoplaston therapy (Atengenal + Astugenal)
-
Houston, TexasBurzynski Clinic
Jan 29, 2018
Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,
Completed
- Adenocarcinoma of the Prostate
- +3 more
- Alisertib
- +2 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Nov 8, 2017
Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in New Brunswick (,
Terminated
- Adenocarcinoma of the Prostate
- +2 more
- placebo
- +2 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Oct 25, 2017